Abiopharma

🔍 Paunovich Vukasin (Executive)

Company: LifeStance Health Group, Inc. (LFST)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 62,935 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: false | shares_owned_after: 327,837.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 18,541 shares of Common Stock at $6.91 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 309,296.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on June 11, 2025, which vested on March 9, 2026.
• F2: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.